Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity - Concepedia

Concepedia

Publication | Open Access

Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity

DOI Full Paper Access

259

Citations

27

References

2021

Year

Steven B. Heymsfield, Laura A. Coleman, Ram R. Miller, Daniel Rooks, Didier Laurent, Olivier Pétricoul, Jens Præstgaard, Therese Swan, Thomas J. Wade, Robert G. Perry,

JAMA Network Open

Abstract

ClinicalTrials.gov number: NCT03005288.

References

	Year	Citations
World Medical Association Declaration of Helsinki JAMA Biomedical EthicEthical PrinciplesResearch EthicsEthical PracticeMedical Tourism	2013	27.3K
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Masafumi Matsuda, Ralph A. DeFronzo Diabetes Care	1999	5.5K
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke, New England Journal of Medicine	2011	729
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise Ele Ferrannini, Silvia Ramos, Afshin Salsali, Diabetes Care	2010	700
Obesity as a Disease: The Obesity Society 2018 Position Statement Ania M. Jastreboff, Catherine M. Kotz, Scott Kahan, Obesity Excess AdiposityMetabolic DisorderCardiometabolic RiskPublic Health NutritionWeight Management	2018	432
Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity Tingqing Guo, William Jou, Tatyana Chanturiya, PLoS ONE	2009	378
An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy Estelle Lach‐Trifilieff, Giulia Minetti, Kelly-Ann Sheppard, Molecular and Cellular Biology Muscle HypertrophySclerostinMuscle FunctionImmunologyCytoskeleton	2013	289
Detection of Insulin Resistance by Simple Quantitative Insulin Sensitivity Check Index QUICKI for Epidemiological Assessment and Prevention Jiří Hřebíček, Vladimír Janout, Jana Malinčíková, The Journal of Clinical Endocrinology & Metabolism HypertensionInsulin Resistance DiagnosticsObesityMetabolic SyndromeBody Composition	2002	284
Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study Daniel Rooks, Jens Præstgaard, Sam Hariry, Journal of the American Geriatrics Society	2017	215
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial Thomas A. Wadden, Jena Shaw Tronieri, Danny Sugimoto, Obesity	2020	183

Page 1